Molecular Classification to Prognosticate Response in Medically Managed Endometrial Cancers and Endometrial Intraepithelial Neoplasia.

导出 OA

翻译打印收藏纠错

作者： Allison M,Puechl ^[1] ; Daniel,Spinosa ^[2] ; Andrew,Berchuck ^[3] ; Angeles Alvarez,Secord ^[3] ; Kerry E,Drury ^[2] ; Gloria,Broadwater ^[4] ; Janice,Wong ^[2] ; Regina,Whitaker ^[3] ; Nicolas,Devos ^[5] ; David L,Corcoran ^[6] ; Kyle C,Strickland ^[7] ; Rebecca A,Previs ^[3]

作者单位： Atrium Health, Division of Gynecologic Oncology, Levine Cancer Institute, Charlotte, NC 29204, USA. ^[1] Department of Obstetrics & Gynecology, Duke University Medical Center, Durham, NC 27710, USA. ^[2] Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA. ^[3] Duke Cancer Institute Biostatistics, Durham, NC 27710, USA. ^[4] GCB, Department of Biostatistics & Bioinformatics, Duke University, Durham, NC 27710, USA. ^[5] Duke Center for Genomics and Computational Biology, Durham, NC 27710, USA. ^[6] Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA. ^[7]

关键词 POLE mutation endometrial cancer levonorgestrel intrauterine device mismatch repair deficiency molecular classification uterine cancer

DOI 10.3390/cancers13112847

PMID 34200374

发布时间 2021-12-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交